IQVIA CFO Ron Bruehlman to Speak at the Morgan Stanley Annual Global Healthcare Conference on September 4, 2024
21 Agosto 2024 - 10:15PM
Business Wire
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) announced today that
Ron Bruehlman, executive vice president and chief financial
officer, will speak at the Morgan Stanley Annual Healthcare
Conference in New York on Wednesday, September 4, 2024 at 10:00
a.m. ET.
A live audio webcast of the presentation will be available on
the IQVIA Investor Relations website at http://ir.iqvia.com. A
replay of the webcast will be available later that day.
About IQVIA
IQVIA (NYSE:IQV) is a leading global provider of clinical
research services, commercial insights and healthcare intelligence
to the life sciences and healthcare industries. IQVIA’s portfolio
of solutions are powered by IQVIA Connected Intelligence™ to
deliver actionable insights and services built on high-quality
health data, Healthcare-grade AI™, advanced analytics, the latest
technologies and extensive domain expertise. With approximately
88,000 employees in over 100 countries, including experts in
healthcare, life sciences, data science, technology and operational
excellence, IQVIA is dedicated to accelerating the development and
commercialization of innovative medical treatments to help improve
patient outcomes and population health worldwide.
IQVIA is a global leader in protecting individual patient
privacy. The company uses a wide variety of privacy-enhancing
technologies and safeguards to protect individual privacy while
generating and analyzing information on a scale that helps
healthcare stakeholders identify disease patterns and correlate
with the precise treatment path and therapy needed for better
outcomes. IQVIA’s insights and execution capabilities help biotech,
medical device and pharmaceutical companies, medical researchers,
government agencies, payers and other healthcare stakeholders tap
into a deeper understanding of diseases, human behaviors and
scientific advances, in an effort to advance their path toward
cures. To learn more, visit www.iqvia.com.
IQVIAFIN
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240821968776/en/
Kerri Joseph, IQVIA Investor Relations (kerri.joseph@iqvia.com)
+1.973.541.3558
Trent Brown, IQVIA Media Relations (trent.brown@iqvia.com)
+1.919.780.3221
Grafico Azioni IQVIA (NYSE:IQV)
Storico
Da Ott 2024 a Nov 2024
Grafico Azioni IQVIA (NYSE:IQV)
Storico
Da Nov 2023 a Nov 2024
